Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

[1]  C. Alpers,et al.  WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity , 2011, The Journal of experimental medicine.

[2]  R. Siegel,et al.  Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. , 2010, Blood.

[3]  A. Villa,et al.  Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. , 2009, Blood.

[4]  Yusuke Suzuki,et al.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.

[5]  Yusuke Suzuki,et al.  Toll-like receptor 9 affects severity of IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[6]  G. Alarcón,et al.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.

[7]  C. Klein,et al.  Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. , 2007, Gastroenterology.

[8]  B. Julian,et al.  Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.

[9]  J. Barratt,et al.  The pathogenic role of IgA1 O‐linked glycosylation in the pathogenesis of IgA nephropathy (Review Article) , 2007, Nephrology.

[10]  B. Julian,et al.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. , 2007, Molecular immunology.

[11]  T. Wada,et al.  Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice. , 2007, The American journal of pathology.

[12]  B. Julian,et al.  IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. , 2005, Kidney international.

[13]  M. Arias,et al.  Inhibition of B Cell Death Causes the Development of an IgA Nephropathy in (New Zealand White × C57BL/6)F1-bcl-2 Transgenic Mice1 , 2004, The Journal of Immunology.

[14]  E. Allenspach,et al.  CD43 Regulation of T Cell Activation Is Not through Steric Inhibition of T Cell–APC Interactions but through an Intracellular Mechanism , 2004, The Journal of experimental medicine.

[15]  H. Kanegane,et al.  IgA nephropathy associated with X-linked thrombocytopenia. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Kohsuke Imai,et al.  Clinical course of patients with WASP gene mutations. , 2004, Blood.

[17]  F. Candotti,et al.  Autoimmunity in Wiskott-Aldrich syndrome , 2003, Current opinion in rheumatology.

[18]  K. Schwarz,et al.  Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. , 2003, Pediatrics.

[19]  H. Yoshida,et al.  Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  B. Julian,et al.  Interactions of human mesangial cells with IgA and IgA-containing immune complexes. , 2002, Kidney international.

[21]  N Seta,et al.  Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. , 2000, Clinical chemistry.

[22]  S. Tsuboi,et al.  Expression of human Wiskott–Aldrich syndrome protein in patients’ cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins , 2000, Gene Therapy.

[23]  B. Julian,et al.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. , 1999, The Journal of clinical investigation.

[24]  S. Chintalacharuvu,et al.  The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. , 1997, Journal of immunology.

[25]  B. Julian,et al.  Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.

[26]  J. Feehally,et al.  Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  I. Binet,et al.  Fatal outcome of renal transplantation in a patient with the Wiskott-Aldrich syndrome. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  K. Sullivan,et al.  A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.

[29]  B. Julian,et al.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. , 1993, Contributions to nephrology.

[30]  J. Dennis,et al.  Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. , 1991, The Journal of biological chemistry.

[31]  D. Lillicrap,et al.  Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. , 1986, The Quarterly journal of medicine.

[32]  L. Spitler,et al.  Nephropathy in the Wiskott-Aldrich syndrome. , 1980, Pediatrics.

[33]  T. Waldmann,et al.  Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism. , 1971, The Journal of clinical investigation.

[34]  J. Opitz,et al.  Familial thrombocytopenia, elevated serum IgA levels and renal disease. A report of a kindred. , 1970, The American journal of medicine.

[35]  J. Berger,et al.  [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.

[36]  W. Sewell,et al.  Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome. , 2008, Medical hypotheses.

[37]  K. Siminovitch,et al.  Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome. , 1993, Immunodeficiency.

[38]  J. Cameron,et al.  Renal transplantation in Wiskott-Aldrich syndrome. , 1993, Transplantation.

[39]  R. Bellomo,et al.  A prospective study of technetium-99m-diethylenetriamine pentaacetic acid renal allograft scintigraphy in the diagnostic evaluation of graft dysfunction. , 1993, Transplantation.

[40]  G. Capasso,et al.  IgA glomerulonephritis in Wiskott-Aldrich syndrome. , 1988, Child nephrology and urology.

[41]  C. Haanen,et al.  [Familial thrombocytopenia]. , 1967, Nederlands tijdschrift voor geneeskunde.